| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044363A1 Methods for modulating apoptotic cell death |
| 06/06/2002 | WO2002044343A2 Tolerizing allografts of pluripotent stem cells |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044336A2 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | WO2002044334A2 Recombinant rsv virus expression systems and vaccines |
| 06/06/2002 | WO2002044330A2 Crystal structure of rotavirus nsp4 peptide |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044205A2 Peptides from ag85 of mycobacterium and uses thereof |
| 06/06/2002 | WO2002044202A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 06/06/2002 | WO2002044197A2 Cytokine receptor binding peptides |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043758A2 Uses of mammalian genes and related reagents |
| 06/06/2002 | WO2002043757A2 Medicament for preventing or treating tumors caused by human papilloma virus type 18 |
| 06/06/2002 | WO2002043756A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 06/06/2002 | WO2002043705A2 Aerodynamically light vaccine for active pulmonary immunization |
| 06/06/2002 | WO2002043699A2 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof |
| 06/06/2002 | WO2002043660A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | WO2002043651A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 06/06/2002 | WO2002043570A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES |
| 06/06/2002 | WO2002043478A2 Transgenic transchromosomal rodents for making human antibodies |
| 06/06/2002 | WO2002043477A1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse |
| 06/06/2002 | WO2002028426A8 Split enveloped virus preparation |
| 06/06/2002 | WO2002026240A3 Inhibition of antigen presentation with poorly catabolized polymers |
| 06/06/2002 | WO2002022674A3 VARIANTS OF THE MAJOR ALLERGEN Par j 2 OF Parietaria judaica |
| 06/06/2002 | WO2002020555A3 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 06/06/2002 | WO2002016440A3 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 06/06/2002 | WO2002005843A3 Human rrp sequences and methods of use |
| 06/06/2002 | WO2002002606A3 Immunisation against chlamydia pneumoniae |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders |
| 06/06/2002 | WO2001068849A3 Human ion channels |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001049324A3 Novel colloid synthetic vectors for gene therapy |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 06/06/2002 | WO2001021810B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/06/2002 | WO2000074630A3 Dna vaccine for protecting an avian against infectious bursal disease virus |
| 06/06/2002 | WO2000022430A3 Neisseria genomic sequences and methods of their use |
| 06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
| 06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 06/06/2002 | US20020068818 Conjugation of biomolecules using diels-alder cycloaddition |
| 06/06/2002 | US20020068719 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 06/06/2002 | US20020068715 DNA construct comprising a sequence encoding an autoantigen associated with a pro-inflammatory, Th1-type T cell response, under the regulatory control of a promoter that is active in a mammalian host. |
| 06/06/2002 | US20020068714 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver. |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068343 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068326 Papillomavirus vaccines |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
| 06/06/2002 | US20020068302 Clasp-4 transmembrane protein |
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068288 Nucleotide sequences for use as anticarcinogenic agents in the treatment of tumors in lungs |
| 06/06/2002 | US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068121 Blends of isoflavones and flavones |
| 06/06/2002 | US20020068090 Useful in vaccines, as carriers for native and recombinant antigens; for treatment of herpes-simplex-virus-2 |
| 06/06/2002 | US20020068071 Enhancement of the cellular immune response |
| 06/06/2002 | US20020068070 High molecular weight major outer membrane protein of moraxella |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068068 Pathogenic bacteria (e.g. Haemophilus, E. Coli, Salmonella) having non-reverting genetic mutations which alter activity of DNA adenine methylase (Dam); vaccines |
| 06/06/2002 | US20020068066 Method for the treatment and prevention of dental caries |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions |
| 06/06/2002 | US20020068058 Autoantibody inhibitors |
| 06/06/2002 | US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/06/2002 | US20020068053 Process for the production of anti-tumor Th1 cells |
| 06/06/2002 | DE10059630A1 Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor Medicines used to prevent or treat by human papillomavirus type 18-evoked tumor |
| 06/06/2002 | DE10055789A1 DNA-Sequenz und Microcin aus Escherichia coli StammDSM 6601 DNA sequence and Microcin from Escherichia coli 6601 StammDSM |
| 06/06/2002 | DE10055285A1 Neue Marker für die Diagnose und Therapie von Tumoren New marker for the diagnosis and therapy of tumors |
| 06/06/2002 | CA2436348A1 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430401A1 Uses of mammalian genes and related reagents |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2430039A1 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies |
| 06/06/2002 | CA2429749A1 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2428595A1 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof |
| 06/06/2002 | CA2427996A1 Tolerizing allografts of pluripotent stem cells |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | CA2402459A1 Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211260A1 Peptides from Ag85 of mycobacterium and uses thereof |